United States (US) Cell And Gene Therapy Manufacturing Market (2025-2031) | Share, Outlook, Forecast, Companies, Industry, Trends, Growth, Value, Segmentation, Competitive Landscape, Analysis, Size & Revenue

Name: United States (US) Cell And Gene Therapy Manufacturing Market (2025-2031) | Share & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Therapy Type (Cell therapy manufacturing, Gene therapy manufacturing), By Scale (Pre-commercial/R&D scale manufacturing, Commercial scale manufacturing), By Mode (Contract manufacturing, In-house manufacturing), By Workflow (Cell processing, Cell banking, Process development, Fill & finish operations, Analytical and quality testing, Raw material testing, Vector production, Others) And Competitive Landscape

Product Code: ETC9962028	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Cell And Gene Therapy Manufacturing Market Outlook
Market Size of United States (US) Cell And Gene Therapy Manufacturing Market, 2024
Forecast of United States (US) Cell And Gene Therapy Manufacturing Market, 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Revenues & Volume for the Period 2021- 2031
United States (US) Cell And Gene Therapy Manufacturing Market Trend Evolution
United States (US) Cell And Gene Therapy Manufacturing Market Drivers and Challenges
United States (US) Cell And Gene Therapy Manufacturing Price Trends
United States (US) Cell And Gene Therapy Manufacturing Porter's Five Forces
United States (US) Cell And Gene Therapy Manufacturing Industry Life Cycle
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Therapy Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Cell therapy manufacturing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Gene therapy manufacturing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Scale for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Pre-commercial/R&D scale manufacturing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Commercial scale manufacturing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Mode for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Contract manufacturing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By In-house manufacturing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Workflow for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Cell processing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Cell banking for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Process development for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Fill & finish operations for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Analytical and quality testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Raw material testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Vector production for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Cell And Gene Therapy Manufacturing Import Export Trade Statistics
Market Opportunity Assessment By Therapy Type
Market Opportunity Assessment By Scale
Market Opportunity Assessment By Mode
Market Opportunity Assessment By Workflow
United States (US) Cell And Gene Therapy Manufacturing Top Companies Market Share
United States (US) Cell And Gene Therapy Manufacturing Competitive Benchmarking By Technical and Operational Parameters
United States (US) Cell And Gene Therapy Manufacturing Company Profiles
United States (US) Cell And Gene Therapy Manufacturing Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Cell And Gene Therapy Manufacturing Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Cell And Gene Therapy Manufacturing Market - Industry Life Cycle

3.4 United States (US) Cell And Gene Therapy Manufacturing Market - Porter's Five Forces

3.5 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.6 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Scale, 2021 & 2031F

3.7 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Mode, 2021 & 2031F

3.8 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Workflow, 2021 & 2031F

4 United States (US) Cell And Gene Therapy Manufacturing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investment in RD for cell and gene therapy advancements

4.2.2 Growing demand for personalized medicine and targeted therapies

4.2.3 Favorable regulatory environment supporting cell and gene therapy manufacturing

4.3 Market Restraints

4.3.1 High cost of cell and gene therapy manufacturing processes

4.3.2 Limited scalability and production challenges in manufacturing

4.3.3 Stringent regulatory requirements for quality control and assurance

5 United States (US) Cell And Gene Therapy Manufacturing Market Trends

6 United States (US) Cell And Gene Therapy Manufacturing Market, By Types

6.1 United States (US) Cell And Gene Therapy Manufacturing Market, By Therapy Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Therapy Type, 2021- 2031F

6.1.3 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell therapy manufacturing, 2021- 2031F

6.1.4 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Gene therapy manufacturing, 2021- 2031F

6.2 United States (US) Cell And Gene Therapy Manufacturing Market, By Scale

6.2.1 Overview and Analysis

6.2.2 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Pre-commercial/R&D scale manufacturing, 2021- 2031F

6.2.3 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Commercial scale manufacturing, 2021- 2031F

6.3 United States (US) Cell And Gene Therapy Manufacturing Market, By Mode

6.3.1 Overview and Analysis

6.3.2 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Contract manufacturing, 2021- 2031F

6.3.3 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By In-house manufacturing, 2021- 2031F

6.4 United States (US) Cell And Gene Therapy Manufacturing Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell processing, 2021- 2031F

6.4.3 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell banking, 2021- 2031F

6.4.4 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Process development, 2021- 2031F

6.4.5 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Fill & finish operations, 2021- 2031F

6.4.6 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Analytical and quality testing, 2021- 2031F

6.4.7 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Raw material testing, 2021- 2031F

6.4.8 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F

6.4.9 United States (US) Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Cell And Gene Therapy Manufacturing Market Import-Export Trade Statistics

7.1 United States (US) Cell And Gene Therapy Manufacturing Market Export to Major Countries

7.2 United States (US) Cell And Gene Therapy Manufacturing Market Imports from Major Countries

8 United States (US) Cell And Gene Therapy Manufacturing Market Key Performance Indicators

8.1 Number of new cell and gene therapy clinical trials initiated in the US

8.2 Percentage of successful cell and gene therapy manufacturing process optimizations

8.3 Average time-to-market for cell and gene therapy products in the US market

9 United States (US) Cell And Gene Therapy Manufacturing Market - Opportunity Assessment

9.1 United States (US) Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.2 United States (US) Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Scale, 2021 & 2031F

9.3 United States (US) Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Mode, 2021 & 2031F

9.4 United States (US) Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Workflow, 2021 & 2031F

10 United States (US) Cell And Gene Therapy Manufacturing Market - Competitive Landscape

10.1 United States (US) Cell And Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024

10.2 United States (US) Cell And Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Cell And Gene Therapy Manufacturing Market

Equatorial Guinea Cell And Gene Therapy Manufacturing Market

Eritrea Cell And Gene Therapy Manufacturing Market

Estonia Cell And Gene Therapy Manufacturing Market

Ethiopia Cell And Gene Therapy Manufacturing Market

Fiji Cell And Gene Therapy Manufacturing Market

Global Cell And Gene Therapy Manufacturing Market

Middle East Cell And Gene Therapy Manufacturing Market

North America Cell And Gene Therapy Manufacturing Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here